Eculizumab for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Randomized-Controlled Trial.

被引：0
|
作者：
Kulkarni, S. [1 ]
Kirkiles-Smith, N. [2 ]
Deng, Y. [3 ]
Formica, R. [4 ]
Gilbert, M. [5 ]
Broeckner, V. [6 ]
Bow, L. [1 ]
Pober, J. [2 ]
机构：
[1] Yale Univ, Surg, New Haven, CT USA
[2] Yale Univ, Immunobiol, New Haven, CT USA
[3] Yale Sch Publ Hlth, Yale Ctr Analyt Sci, New Haven, CT USA
[4] Yale Univ, Med, New Haven, CT USA
[5] Yale Univ, Pathol, New Haven, CT USA
[6] Univ Cambridge, Histopathol, Cambridge, England
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A222
引用
收藏
页码：475 / 476
页数：2
相关论文
共 50 条
  • [21] Use of Tocilizumab in the treatment of chronic active antibody-mediated rejection in pediatric kidney transplant recipients
    Sangermano, Maria
    Negrisolo, Susanna
    Antoniello, Benedetta
    Vadori, Marta
    Cozzi, Emanuele
    Benetti, Elisa
    HUMAN IMMUNOLOGY, 2024, 85 (05)
  • [22] Anti-Interleukin 6 Therapeutics for Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients
    Sharma, Rajeev
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (08) : 709 - 716
  • [23] USE OF TOCILIZUMAB IN THE TREATMENT OF CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Sangermano, Maria
    Negrisolo, Susanna
    Antoniello, Benedetta
    Carraro, Andrea
    Vadori, Marta
    Cuciz, Elisa
    Longo, Germana
    Vidal, Enrico
    Meneghesso, Davide
    Parolin, Mattia
    Cozzi, Emanuele
    Benetti, Elisa
    PEDIATRIC NEPHROLOGY, 2023, 38 : S52 - S53
  • [24] Urinary Proteomic Biomarkers for Prediction of Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients.
    Jung, H.
    Jeong, K.
    Lim, J-H.
    Choi, J.
    Cho, J-H.
    Park, S-H.
    Kim, Y-L.
    Lee, C-H.
    Baek, M-C.
    Chung, B.
    Lee, S-H.
    Kim, C-D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 775 - 775
  • [25] Tocilizumab in Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: A Case Series.
    Boonpheng, B.
    Bakthavatsalam, R.
    Blosser, C. D.
    De Castro, I. C.
    Gimferrer, I.
    Ng, Y.
    Leca, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 959 - 959
  • [26] CLINICAL SIGNIFICANCE OF DE NOVO DONOR SPECIFIC ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS WITH CHRONIC ANTIBODY-MEDIATED REJECTION
    Park, Woo Yeong
    Paek, Jin Hyuk
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    TRANSPLANT INTERNATIONAL, 2019, 32 : 102 - 102
  • [27] Costs of Treatment of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients
    Labus, Anna L.
    Mucha, Krzysztof
    Kulesza, Andrzej
    Fliszkiewicz, Magda
    Paczek, Leszek
    Niemczyk, Mariusz
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (04) : 968 - 971
  • [28] Use of Eculizumab for Rescue Therapy of a Severe Antibody-Mediated Rejection in a Living Kidney Transplant
    Silvestre, C.
    Furian, L.
    Marson, P.
    Tison, T.
    Pierobon, E. S.
    Donato, P.
    Seveso, M.
    Valente, M. L.
    Cozzi, E.
    Rigotti, P.
    TRANSPLANTATION, 2012, 94 (10) : 1071 - 1071
  • [29] Ciprofloxacin for BK Viremia Prophylaxis in Kidney Transplant Recipients: Results of a Prospective, Randomized Controlled Trial.
    Patel, S.
    Kuten, S.
    Knight, R.
    Nolte, J.
    Nguyen, D.
    Graviss, E.
    Moore, L.
    Agboli, I.
    Pham, C.
    Gaber, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 299 - 299
  • [30] Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab-A Preliminary Study
    Arrive, Capucine
    Jacquet, Marvin
    Gautier-Veyret, Elodie
    Jouve, Thomas
    Noble, Johan
    Lombardo, Dorothee
    Rostaing, Lionel
    Stanke-Labesque, Francoise
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
12345